SANUWAVE Health Inc
sanuwave.comSANUWAVE Health Inc (OTC: SNWV) is a medical device company that develops and commercializes devices subject to FDA regulation. Revenue is transactional, generated through the sale and use of medical devices, with third-party reimbursement anticipated as a component of the commercial model as described in the FY2025 10-K filed March 26, 2026. The company operates in the United States healthcare market and is subject to federal and state anti-kickback statutes, FDA oversight, and healthcare fraud and abuse laws applicable to medical device manufacturers. SNWV does not pay cash dividends and has stated its intent to retain any future earnings to finance operations. As of the FY2025 filing, Morgan Frank serves as Chief Executive Officer. The company's capital structure includes debt with associated issuance costs and discounts, derivative liabilities, and stock-based compensation, indicating a leveraged balance sheet with no dividend distributions.
Products & Services
FDA-regulated medical devices; the filing references a PACE product line with inventory written off related to PACE disposal during FY2025. Patent assets were also sold during FY2025.
Revenue Model
Transactional revenue from sale of medical devices; third-party reimbursement from payors anticipated as part of the commercial model per the FY2025 10-K.
Customers & Markets
Hospitals, physicians, and other healthcare purchasers in the United States. End market is U.S. healthcare, with reimbursement dependent on third-party payors including federal healthcare programs.
Geographic Exposure
United States, based on regulatory framework described in the FY2025 10-K.
Loading...
